Problem: Wittpharm Case Study
A. Beyond the estimated development costs, are there other costs to WittPharm if you choose to pursue the drug? If yes, what are they? Are there costs of not pursuing the drug? If yes, what are they?
B. Are there any potential benefits to WittPharm of pursuing the drug? If so, what are they? How easy or difficult would it be to quantify any of those potential benefits?
C. What would your mission and values suggest that you do?
D. The final decision rests in your hands as WittPharm's CEO. Based on the discussion of the previous questions, do you pursue the drug? Why or why not?
E. Who are the winners and losers as a result of your decision?